Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 17-AAG | 0.01 | uM | 7 | 1250.00 | 859.67 | 918.00 | 1644.00 | 0.5584 | 0.0727 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 7 | 1250.00 | 859.67 | 687.00 | 1644.00 | 0.4179 | -0.2131 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 7 | 1250.00 | 859.67 | 651.00 | 1644.00 | 0.3960 | -0.2571 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 1250.00 | 859.67 | 1507.00 | 1644.00 | 0.9167 | 0.8223 |
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 1250.00 | 859.67 | 1406.00 | 1644.00 | 0.8552 | 0.6921 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 7 | 1250.00 | 859.67 | 1494.00 | 1644.00 | 0.9088 | 0.8055 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 7 | 1250.00 | 859.67 | 827.00 | 1644.00 | 0.5030 | -0.0406 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 7 | 1250.00 | 859.67 | 663.00 | 1644.00 | 0.4033 | -0.2425 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 1250.00 | 859.67 | 1798.00 | 1644.00 | 1.0937 | 1.2009 |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 1671.00 | 1644.00 | 1.0164 | 1.0351 | |
| SK-BR-3 | Linsitinib | 0.1 | uM | 7 | 1250.00 | 859.67 | 1650.00 | 1644.00 | 1.0036 | 1.0078 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 7 | 1250.00 | 859.67 | 1611.00 | 1644.00 | 0.9799 | 0.9571 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 7 | 1250.00 | 859.67 | 1404.00 | 1644.00 | 0.8540 | 0.6895 |
| SK-BR-3 | Linsitinib | 1 | uM | 7 | 1250.00 | 859.67 | 1219.00 | 1644.00 | 0.7415 | 0.4526 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 7 | 1250.00 | 859.67 | 1274.00 | 1644.00 | 0.7749 | 0.5228 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 7 | 1250.00 | 859.67 | 1579.00 | 1644.00 | 0.9605 | 0.9156 |
| SK-BR-3 | 17-AAG | 1 | uM | 7 | 1250.00 | 859.67 | 668.00 | 1644.00 | 0.4063 | -0.2364 |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 1506.00 | 1644.00 | 0.9161 | 0.8211 | |
| SK-BR-3 | Lapatinib | 0.1 | uM | 7 | 1250.00 | 859.67 | 1096.00 | 1644.00 | 0.6667 | 0.2965 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 7 | 1250.00 | 859.67 | 1263.00 | 1644.00 | 0.7683 | 0.5088 |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 1549.00 | 1644.00 | 0.9422 | 0.8767 | |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 7.00 | 1644.00 | 0.0043 | -0.9942 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 11.00 | 3582.00 | 0.0031 | -0.9961 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3609.00 | 3582.00 | 1.0075 | 1.0162 | |
| SK-BR-3 | 17-AAG | 3.1623 | uM | 7 | 2500.00 | 1881.33 | 1672.00 | 3582.00 | 0.4668 | -0.1192 |